Olympus' first domestically produced product receives approval

Smart Medical Device Network NewsRecently, Olympus1500Gastroscopy (GIF-EZ1500-C)Approved, registration number: Su Medical Device Registration Approval20252061650, and this is Olympus' first domestic product certification. This product is mainly used for detailed examination and screening of early upper gastrointestinal cancer, as well as magnified endoscopic observation of suspicious lesions.

It is understood that,GIF-EZ1500Gastroscopes employ additional illumination channels.3(bundle) piece, compared toGIF-HQ290andGIF-H290TMore gastroscopies1The bundle arrangement from the distal end appears triangular, providing more uniform illumination. Judging from the lens distal arrangement design, bending angle design, and biopsy channel diameter, this scope still maintains Olympus's characteristic style of specialized, compact integration—dedicated scopes for specific purposes, primarily intended for diagnostic examinations.

GIF-EZ1500The auxiliary water outlet is slightly to the left of the center, close to the center of the field of view. Positioning the outlet near the center allows for precise and direct irrigation during treatment. Additionally, the proximity of the auxiliary water outlet to the instrument channel enables more timely and accurate irrigation during hemostasis.

In terms of technology, Olympus endoscopes employ advanced optical imaging technology to provide high-resolution images, enabling doctors to clearly observe details of internal body structures. Their high-definition image quality helps improve diagnostic accuracy.

At the same time, Olympus endoscopes are designed with emphasis on operational flexibility; their slender insertion tubes can easily access various parts of the human body, while offering excellent maneuverability and bending capability to accommodate different patients' anatomical structures. Moreover, Olympus endoscopes integrate multiple advanced functions, such as narrow-band imaging technology (NBI), electronic staining technology, etc., these functions help better identify lesion tissues and improve the chances of early diagnosis.

Olympus announced several months ago that it would2026year3Operate an endoscope assembly plant in Suzhou, Jiangsu Province, China within the fiscal year, and simultaneously deepen collaboration with Chinese medical institutions on physician training.

Actually, Olympus has been2025Since the beginning of the year, we have gradually advanced the localization strategy by establishing an endoscopy manufacturing plant and transferring production to China. This move not only responds to local market demand in China, but also reduces logistics costs and improves after-sales service response speed.

The data shows that Olympus' Suzhou factory will initially focus on endoscope assembly, gradually expanding later to the production of core components. This move aims to circumvent import tariff barriers and respond to China's medical device regulations."Made in China substitution" policy orientation. In fact, in2023year2In August, Olympus officially decided to establish its China medical equipment production and R&D base in Suzhou Industrial Park, Jiangsu.

Moreover, according to Olympus2025Fiscal year (ended2025year3Financial report data showed that its global revenue and profits both declined, with the Chinese market continuing to face pressure due to the medical anti-corruption policy, becoming the key factor dragging down the group's performance. Sales in the Chinese market957hundred million yen (approximately RMB45(billion yuan), a year-on-year decrease9%, accounting for the proportion of the group's total revenue from13%Drop to11%, with two consecutive years of negative growth.